To study the short-term effects of theophylline on sleep and wakefulness, 24 
. 6'7 Theophylline, another methykanthine, has been shown in several studies to have no effect on the nighttime sleep of patients with COPD or asthma. 8, 9 However, in such patient populations, it is difficult to clearly determine the pharmacologic effects of theo¬ phylline. Patients Manuscript received August 17, 1994 ; revision accepted March 9, 1995. Reprint requests: Dr. Roehrs 
Study Procedures
To determine whether therapeutic serum levels were being achieved for the highest theophylline dose, on a separate day prior to the dose effect assessments, each subject in both groups received a liquid form of theophylline (6 
Results
The serum levels of theophylline (6 mg/kg) after the 9 am administration are presented in Table 2 for both the daytime and nighttime administration groups.
There were no differences between the groups in se¬ rum levels. On average, serum levels peaked at 11.0 pg/mL and declined to only 8.1 pg/mL at 7.5 h postadministration at the approximate time both daytime and nighttime assessments were concluded.
Dose Effects After Nighttime Administration
The nocturnal polysomnographic parameters for each dose are presented in Table 3 Table 4 . There was a significant main effect ofdose (F2,22= 14.61, p<0.001) with the low and high doses both increasing sleep la¬ tency relative to placebo, but not differing from each other. There was no main effect of time, but there was a significant time by dose interaction (F6,66=2.81, p<0.01). The significant dose differences were ob¬ served on the first (10 am) and second (12 noon) latency tests, but not on the latter two tests. The dose-related effects of theophylline on nocturnal and daytime sleep latencies are compared in Figure 3 . The low dose had minimal effects on the nocturnal sleep latency (see nighttime administration paragraph above), while it increased sleep latency during the daytime.
The divided attention and auditory vigilance per¬ formance measures from the morning assessment are presented in Table 5 Figure 1 shows, there were some subject differences in the high-dose effects on sleep time; not all subjects had increased wakefulness to the high dose compared with the low dose. About halfofthe subjects showed somewhat smaller increases in wakefulness (20 to 30 min).
The nocturnal sleep disturbance found in this study can be compared with that reported in a previous 
